ES413100A1 - Un metodo para obtener una sustancia inmunogena. - Google Patents

Un metodo para obtener una sustancia inmunogena.

Info

Publication number
ES413100A1
ES413100A1 ES413100A ES413100A ES413100A1 ES 413100 A1 ES413100 A1 ES 413100A1 ES 413100 A ES413100 A ES 413100A ES 413100 A ES413100 A ES 413100A ES 413100 A1 ES413100 A1 ES 413100A1
Authority
ES
Spain
Prior art keywords
haemolytica
multocida
substance
serotype
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES413100A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES413100A1 publication Critical patent/ES413100A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES413100A 1972-03-29 1973-03-28 Un metodo para obtener una sustancia inmunogena. Expired ES413100A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1491072 1972-03-29
GB593573*[A GB1441098A (en) 1972-03-29 1973-02-07 Biological preparations

Publications (1)

Publication Number Publication Date
ES413100A1 true ES413100A1 (es) 1976-06-01

Family

ID=26240265

Family Applications (1)

Application Number Title Priority Date Filing Date
ES413100A Expired ES413100A1 (es) 1972-03-29 1973-03-28 Un metodo para obtener una sustancia inmunogena.

Country Status (9)

Country Link
JP (1) JPS496118A (show.php)
DE (1) DE2315563A1 (show.php)
ES (1) ES413100A1 (show.php)
FR (1) FR2182909B1 (show.php)
GB (1) GB1441098A (show.php)
HU (1) HU171383B (show.php)
IL (1) IL41902A (show.php)
IT (1) IT1035061B (show.php)
NL (1) NL7304320A (show.php)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000412A1 (en) * 1978-08-24 1980-03-20 N Gilmour Pasteurellosis vaccines
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4388299A (en) 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
NL8200392A (nl) * 1982-02-03 1983-09-01 Duphar Int Res Werkwijze ter bereiding van een immunogeen van pasteurella multocida.
JPH0662433B2 (ja) * 1984-04-23 1994-08-17 財団法人日本生物科学研究所 ヘモフイルス・パラガリナ−ラムの粉状ワクチン製造法
GB2202851B (en) * 1987-03-24 1990-12-19 Nat Res Dev Proteinaceous material of p. haemolytica and vaccine against pasteurella
MX9301736A (es) * 1992-03-30 1994-01-31 Smithkline Beecham Corp Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.

Also Published As

Publication number Publication date
DE2315563A1 (de) 1973-10-11
HU171383B (hu) 1977-12-28
GB1441098A (en) 1976-06-30
NL7304320A (show.php) 1973-10-02
JPS496118A (show.php) 1974-01-19
IT1035061B (it) 1979-10-20
IL41902A0 (en) 1973-05-31
FR2182909B1 (show.php) 1976-04-09
FR2182909A1 (show.php) 1973-12-14
IL41902A (en) 1976-03-31

Similar Documents

Publication Publication Date Title
ES413100A1 (es) Un metodo para obtener una sustancia inmunogena.
NL7509550A (nl) Werkwijze ter bereiding van benzoylureidodifenyl- ethers, werkwijze ter bereiding van insecticide preparaten en gevormde preparaten.
SE7503145L (sv) Forfarande for framstellning av rekonstituerade tobaksmaterial.
FR2275203A1 (fr) 5-propylthio-2-benzimidazolecarbamate de methyle, ses procedes de preparation et ses applications
SE401175B (sv) Forfarande for framstellning av en ogiftig och icke fororenande, biologiskt nedbrytbar, komplexbindande komposition, huvudsakligen innehallande natriumsaltet av n,n-bis (karboximetyl)glutaminsyra
Springer et al. Cross reactive human blood-group H (O) specific polysaccharide from Sassafras albidum and characterization of its hapten
IL47845A (en) Method for the preparation of fibres incorporating antibodies, antigens and antisera
SE8000966L (sv) Agaroskomposition och gel
GB1218277A (en) Dry water-dispersible aluminium hydroxide gels
AT320149B (de) Verfahren zur Herstellung eines attenuierten, modifizierten Pockenschutzimpfstoffes
BE866464A (fr) Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires.
KR920006004A (ko) 헤모필루스 파라갈리나룸 (Haemophilus paragallinaum)왁찐
NL174555C (nl) Werkwijze voor de bereiding van gemodificeerde entcopolymeren van cellulose met monovinylmonomeren, alsmede geheel of gedeeltelijk daaruit vervaardigd textielmateriaal.
IL49459A (en) Gonococcal pilin and other materials isolated from pili of neisseria gonorrhoeae compositions and vaccines containing them and method of testing the presence of antibodies to n. gonorrhoeae pili
ES412270A1 (es) Metodo para preparar arabinofuranosil citosinas.
NL174259C (nl) Werkwijze ter bereiding van waterhoudende stabiele coagulaatvrije, silanolgroepen bevattende polymeer dispersies en verven of kunststof pleistermateriaal daaruit.
IT1040155B (it) Procedimento per la preparazione di eteri clicidilici di fenoli monovalenti o polivalenti con proprieta migliorate
SE8205247D0 (sv) Fiskvacciner
ES394117A1 (es) Procedimiento de preparacion de principios medicinales ac- tivos.
ES415281A1 (es) Procedimiento de tenaplenado.
ZA734632B (en) Cancer associated polypeptide antigen,process for its preparation,process for preparing antibodies,process of cancer diagnosis and composition useful as an immunizing agent
ES444580A1 (es) Procedimiento de conservacion de vacunas que contienen mi- crobacterias vivientes.
BE842814A (fr) Compositions antigeniques, leur procede de preparation et leur application comme vaccins
AT325221B (de) Verfahren zur herstellung neuer derivate des 6alpha-methylprednisolons
JPS5249566A (en) Method of measuring fish or other sunstances